These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26011233)

  • 1. Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma.
    Fatourou E; Koskinas J; Karandrea D; Palaiologou M; Syminelaki T; Karanikolas M; Felekouras E; Antoniou E; Manesis EK; Delladetsima J; Tiniakos D
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1094-102. PubMed ID: 26011233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules.
    Zhang Q; Zhang CS; Xin Q; Ma Z; Liu GQ; Liu BB; Wang FM; Gao YT; Du Z
    World J Gastroenterol; 2014 Aug; 20(31):10908-15. PubMed ID: 25152593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
    Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.
    Govaere O; Komuta M; Berkers J; Spee B; Janssen C; de Luca F; Katoonizadeh A; Wouters J; van Kempen LC; Durnez A; Verslype C; De Kock J; Rogiers V; van Grunsven LA; Topal B; Pirenne J; Vankelecom H; Nevens F; van den Oord J; Pinzani M; Roskams T
    Gut; 2014 Apr; 63(4):674-85. PubMed ID: 23958557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
    Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
    J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.
    Rhee H; Nahm JH; Kim H; Choi GH; Yoo JE; Lee HS; Koh MJ; Park YN
    Mod Pathol; 2016 Sep; 29(9):1038-49. PubMed ID: 27312064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
    Ahn S; Hyeon J; Park CK
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic progenitor cells in liver cancers from Asian children.
    Ward SC; Thung SN; Lim KH; Tran TT; Hong TK; Hoang PL; Jang JJ; Park YN; Abe K
    Liver Int; 2010 Jan; 30(1):102-11. PubMed ID: 19793197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.
    Kim GJ; Kim H; Park YN
    PLoS One; 2013; 8(9):e75449. PubMed ID: 24086533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.
    Cai X; Zhai J; Kaplan DE; Zhang Y; Zhou L; Chen X; Qian G; Zhao Q; Li Y; Gao L; Cong W; Zhu M; Yan Z; Shi L; Wu D; Wei L; Shen F; Wu M
    Hepatology; 2012 Nov; 56(5):1804-16. PubMed ID: 22684921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Tsuchiya K; Komuta M; Yasui Y; Tamaki N; Hosokawa T; Ueda K; Kuzuya T; Itakura J; Nakanishi H; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Sakamoto M; Izumi N
    Oncology; 2011; 80(3-4):278-88. PubMed ID: 21734420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
    Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
    Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
    Kim H; Park YN
    Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.
    Wang L; Yao M; Fang M; Zheng WJ; Dong ZZ; Pan LH; Zhang HJ; Yao DF
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):227-232. PubMed ID: 29709351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases.
    Liu TC; Vachharajani N; Chapman WC; Brunt EM
    Am J Surg Pathol; 2014 Jul; 38(7):966-72. PubMed ID: 24805857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.
    Govaere O; Petz M; Wouters J; Vandewynckel YP; Scott EJ; Topal B; Nevens F; Verslype C; Anstee QM; Van Vlierberghe H; Mikulits W; Roskams T
    Oncogene; 2017 Nov; 36(47):6605-6616. PubMed ID: 28783171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma.
    Xu M; Xie F; Qian G; Jing Y; Zhang S; Gao L; Zheng T; Wu M; Yang J; Wei L
    BMC Cancer; 2014 Feb; 14():65. PubMed ID: 24495509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.
    Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF
    World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.